Novo Nordisk A/S NVO
$ 109.93
-1.8%
Annual report 2023
added 11-02-2024
Country |
Danmark |
IPO year |
- |
Industry |
Biotechnology |
Stock Exchange |
NYSE |
CEO |
Mr. Lars Fruergaard Jrgensen |
Employees in the company |
44 326 |
Shares |
- |
Market Cap[1] |
$ 421 B |
EBITDA (LTM) |
- |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
- |
Other stocks of industry "Biotechnology"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.